hypericin has been researched along with ATLL in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Hypericin (HY) is a new-type of photosensitizer in the context of photodynamic therapy (PDT) due to its excellent photosensitizing properties and anti-tumor activities." | 1.51 | Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription. ( Cheng, W; Shao, L; Wang, Y; Wang, Z; Xu, L; Yi, K; Zhang, X; Zhang, Y; Zhao, T, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xu, L | 1 |
Zhang, X | 1 |
Cheng, W | 1 |
Wang, Y | 1 |
Yi, K | 1 |
Wang, Z | 1 |
Zhang, Y | 1 |
Shao, L | 1 |
Zhao, T | 1 |
1 other study available for hypericin and ATLL
Article | Year |
---|---|
Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Human T-lymphotropic vi | 2019 |